NCT03141658View on ClinicalTrials.gov

Effects of TS-134 on Ketamine-induced BOLD Signals in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

June 28, 2017

Primary Completion Date

April 4, 2018

Study Completion Date

April 10, 2018

Conditions
Healthy Volunteers
Interventions
DRUG

TS-134

Multiple dose titrations from 10 mg to 20 mg once daily for 6 days

DRUG

TS-134

Multiple dose titrations from 10 mg to 60 mg once daily for 6 days

DRUG

Placebo

Multiple doses of placebo once daily for 6 days

OTHER

Ketamine

0.23 mg/kg bolus over one minute on Screening (baseline) and Day 6

Trial Locations (1)

10032

New York State Psychiatric Institute, New York

All Listed Sponsors
lead

Taisho Pharmaceutical R&D Inc.

INDUSTRY

NCT03141658 - Effects of TS-134 on Ketamine-induced BOLD Signals in Healthy Subjects | Biotech Hunter | Biotech Hunter